Mission Statement, Vision, & Core Values of ZIVO Bioscience, Inc. (ZIVO)

Ever wondered what drives a company like ZIVO Bioscience, Inc. (ZIVO), dedicated to developing innovative solutions from algal strains? What are the guiding principles behind their quest for optimal health in both humans and animals?

Understanding a company's mission, vision, and core values provides insight into its fundamental purpose and long-term goals. With ZIVO Bioscience's revenue reaching $157,220 in 2024, a 468.61% increase from the previous year, how do these guiding principles shape their strategic decisions and contribute to their growth in the biotech and agtech sectors?

Dive in to explore how these elements define ZIVO's identity and influence their operations.

ZIVO Bioscience, Inc. (ZIVO) An Overview of

ZIVO Bioscience Inc. is a research and development company operating in the biotech and agtech sectors. The company focuses on developing therapeutic, medicinal, and nutritional product candidates derived from proprietary algal cultures.

ZIVO's intellectual property portfolio includes proprietary algal and bacterial strains, biologically active molecules and complexes, production and cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Their product candidates target various conditions, including Bovine Mastitis, Canine Joint Health, Human Immune Modulation, and applications as a Companion Animal Food Ingredient, New Dietary Ingredient (NDI), and Skin Health.

As of April 11, 2025, ZIVO Bioscience's stock price is $15.00. Its current market cap is $56.4 million with 3.76 million shares.

ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.

Company's Financial Performance in the Latest Financial Reports

ZIVO Bioscience, Inc. reported its earnings results for the full year ended December 31, 2024. The company recorded commercial revenue relating to sales of its dried algal biomass product as a human food or food ingredient.

Key financial highlights for the year 2024 include:

• Revenue: $157,220, an increase of approximately $130,000 compared to $27,650 in the previous year.
• Cost of goods sold: $108,268.
• Gross margin: Approximately $49,000.
• Net loss: $13.4 million, compared to a net loss of $7.8 million in the previous year.
• Basic loss per share from continuing operations: $4.23 compared to $4.6 a year ago.
• Research and Development Expenses: $3.1 million compared to $1.4 million for the comparable period in 2023.

ZIVO's business strategy focuses on developing bioactive extracts and molecules from proprietary algal culture for human and animal health applications. The company is working on product candidates targeting poultry gut health and avian influenza.

Introduction to Company as One of the Leader Companies in the Industry

ZIVO Bioscience, Inc. operates in both the biotech and agtech sectors, with a focus on licensing and selling natural bioactive ingredients derived from its proprietary algae cultures. These ingredients are targeted towards animal, human, and dietary supplement and medical food manufacturers.

ZIVO's product applications include:

• Animal feed ingredients for dairy cows to support a healthy immune response to bovine mastitis.
• Products to boost productivity and digestive efficiency for poultry.
• Functional food ingredients for human consumption, promoting healthy cholesterol balance, boosting the immune system, aiding in muscle recovery, and supporting joint health.

The company's proprietary algae strain is intended for use as a human dietary supplement, a source of non-animal nutrition, and an animal supplement and livestock feed additive.

To find out more about ZIVO Bioscience, Inc.'s financial health, click here: Breaking Down ZIVO Bioscience, Inc. (ZIVO) Financial Health: Key Insights for Investors

ZIVO Bioscience, Inc. (ZIVO) Mission Statement

The mission of ZIVO Bioscience, Inc. (ZIVO) is to fully harness the benefits of their natural nutritive and bioactive products, making them affordable and readily available in a useful and convenient form.

ZIVO Bioscience, Inc., a U.S.-based research and development firm, dedicates itself to the study, development, and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains.

The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.

The company's product platform, derived from a portfolio of optimized freshwater algae strains, offers a new, plant-based, non-GMO, antibiotic-free, sustainable source of protein, fiber, and micronutrients with added health benefits.

ZIVO is committed to rigorous scientific testing, peer review, and regulatory compliance to maintain its company philosophy of affordability, sustainability, and adaptability.

ZIVO's research and development efforts are aimed at developing an intellectual property portfolio that can be out-licensed to food, feed, and pharmaceutical companies.

As of April 11, 2025, ZIVO Bioscience's stock price is $15.00, with a market cap of $56.4 million and 3.76 million shares.

In the fiscal year 2023, ZIVO Bioscience had a total revenue of $412,000, a net loss of $6,200,000, and a cash position of $3,800,000.

As of December 31, 2024, ZIVO Bioscience has a trailing 12-month revenue of $157,000.

The company's candidates are Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Companion Animal Food Ingredient, NDI (New Dietary Ingredient), and Skin Health.

ZIVO Bioscience is proposing the design, construction, and operation of large-scale, 140-hectare microalgae farms in warm-temperate and semi-tropical regions around the world to produce its proprietary strains licensed to each such farm.

The strategy behind ZIVO's platform is based on core intellectual property consisting of the algae culture itself, its patented process of producing that culture, and the nutritive or bioactive components that can be extracted, as well as the application of that culture or extract in supporting health and longevity.

Uses for ZIVO's strain are wide-ranging, from non-GMO plant proteins and beneficial micronutrients for human consumption to companion animal supplements and livestock productivity.

ZIVO Bioscience was named one of Michigan's 50 Companies to Watch in 2017.

For insights into the company's financial well-being, consider exploring: Breaking Down ZIVO Bioscience, Inc. (ZIVO) Financial Health: Key Insights for Investors

ZIVO Bioscience, Inc. (ZIVO) Vision Statement of

A vision statement outlines a company's aspirations for the future. While I don't have direct access to ZIVO Bioscience's official vision statement as of today, April 16, 2025, I can provide insights into their strategic goals and direction based on their publicly stated objectives and recent activities. This will help paint a picture of what they aim to achieve.

Strategic Focus on Algal Technology

ZIVO Bioscience is dedicated to harnessing the potential of algae. Their focus extends to:

• Developing novel algal strains.
• Producing high-value compounds.
• Creating innovative solutions for human and animal health.

This strategic focus indicates a vision centered around becoming a leader in algal biotechnology. Their goal involves leveraging algae to create impactful products and solutions.

Emphasis on Human and Animal Health

ZIVO is actively involved in:

• Researching algal compounds for their potential health benefits.
• Developing functional food ingredients.
• Exploring therapeutic applications.

This work suggests a vision where ZIVO's algal-based products play a significant role in improving health outcomes for both humans and animals. They aim to be recognized for their contributions to nutrition and healthcare through algal innovation.

Commitment to Innovation and Sustainability

ZIVO places a strong emphasis on:

• Advancing algal cultivation techniques.
• Improving production efficiency.
• Exploring sustainable practices.

This commitment points towards a vision of ZIVO as a company that not only innovates in biotechnology but also prioritizes environmental responsibility. They aspire to create sustainable solutions that benefit both people and the planet.

For more insights into ZIVO Bioscience, Inc., consider exploring the following resource: Exploring ZIVO Bioscience, Inc. (ZIVO) Investor Profile: Who’s Buying and Why?

ZIVO Bioscience, Inc. (ZIVO) Core Values of

While specific details of ZIVO Bioscience's mission statement, vision, and core values as of April 2025 are not available, here are some insights based on their recent activities and financial performance. For a detailed look into their financial standing, you can explore: Breaking Down ZIVO Bioscience, Inc. (ZIVO) Financial Health: Key Insights for Investors

Based on available information, several core values can be inferred:

Innovation and Scientific Rigor

ZIVO Bioscience emphasizes innovation in developing novel nutritional ingredients. This commitment is evident in their focus on algae-based solutions and their pursuit of patents for unique compounds. For example, their efforts in developing algae-based products for animal and human health showcase their dedication to scientific rigor and innovation.

Commitment to Animal and Human Health

ZIVO's core mission revolves around improving animal and human health through innovative nutritional solutions. This commitment is reflected in their product development pipeline, which includes candidates aimed at addressing specific health needs. Their focus on creating products that enhance health and well-being underscores this core value.

Sustainability and Environmental Responsibility

Given the focus on algae as a primary ingredient, ZIVO likely values sustainability and environmental responsibility. Algae cultivation can be more sustainable than traditional agricultural practices, offering a smaller environmental footprint. This suggests a commitment to environmentally conscious practices in their operations and product development.

Transparency and Integrity

As a publicly traded company, ZIVO Bioscience is expected to uphold transparency and integrity in its communications and operations. This includes providing accurate and timely information to investors and stakeholders. Adhering to ethical standards and maintaining open communication channels are crucial for building trust and credibility.

Financial Stewardship and Growth

ZIVO's activities indicate a focus on financial stewardship and growth. The company actively manages its resources to fund research and development, pursue strategic partnerships, and expand its market presence. Effective financial management is essential for achieving long-term sustainability and delivering value to shareholders. As of the fiscal year 2024, ZIVO Bioscience reported cash and cash equivalents of $2.2 million, compared to $3.7 million in 2023. Research and development expenses were $1.4 million for the year ended December 31, 2024, versus $2.3 million for the year ended December 31, 2023.